Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amantadine 100mg capsules
0409010B0AAAAAA
|
Amantadine hydrochloride (Parkinsonism) | Amantadine hydrochloride | Central Nervous System | 35,631 |
|
CosmoCol Paediatric oral powder 6.9g sachets
0106040M0BGADAB
|
CosmoCol | Macrogol 3350 | Gastro-Intestinal System | 35,606 |
|
Adizem-XL 180mg capsules
0206020C0BFAHAV
|
Adizem-SR | Diltiazem hydrochloride | Cardiovascular System | 35,561 |
|
Methylphenidate 10mg tablets
0404000M0AAAAAA
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 35,538 |
|
Sharpsafe disposal unit 4 litre
21010900462
|
Sharpsafe disposal unit 4 litre | Other Appliances | Appliances | 35,429 |
|
Bimatoprost 300microg/Timolol 5mg/ml eye dps 0.4ml
1106000AIAAABAB
|
Timolol/bimatoprost | Timolol and bimatoprost | Eye | 35,368 |
|
Duloxetine 40mg gastro-resistant capsules
0704020AAAAABAB
|
Duloxetine hydrochloride | Duloxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 35,267 |
|
Azithromycin 250mg capsules
0501050A0AAAAAA
|
Azithromycin | Azithromycin | Infections | 35,234 |
|
Fenofibrate micronised 267mg capsules
0212000P0AAADAD
|
Fenofibrate | Fenofibrate | Cardiovascular System | 35,136 |
|
Cyanocobalamin 1mg modified-release tablets
0901020D0AAAHAH
|
Cyanocobalamin | Cyanocobalamin | Nutrition and Blood | 35,107 |
|
Oilatum cream
130201000BBJPCD
|
Proprietary compound emollients | Other emollient preparations | Skin | 35,098 |
|
Hydralazine 25mg tablets
0205010J0AAAGAG
|
Hydralazine hydrochloride | Hydralazine hydrochloride | Cardiovascular System | 35,095 |
|
Ketoprofen 2.5% gel
100302010AAAAAA
|
Ketoprofen (Topical) | Ketoprofen | Musculoskeletal and Joint Diseases | 35,064 |
|
Clarithromycin 250mg tablets
0501050B0AAAAAA
|
Clarithromycin | Clarithromycin | Infections | 35,057 |
|
Nasofan 50micrograms/dose aqueous nasal spray
1202010M0BCAAAC
|
Nasofan | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 35,051 |
|
Ivabradine 2.5mg tablets
0206030Y0AAACAC
|
Ivabradine | Ivabradine | Cardiovascular System | 35,029 |
|
Oxybutynin 10mg modified-release tablets
0704020J0AAATAT
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 35,023 |
|
Tamsulosin 400microgram modified-release tablets
0704010U0AAABAB
|
Tamsulosin hydrochloride | Tamsulosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 34,936 |
|
Hyoscine butylbromide 20mg/1ml inj ampoules
0102000N0AAAAAA
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 34,889 |
|
Lantus 100units/ml solution for injection 3ml cartridges
0601012V0BBAAAA
|
Insulin Lantus | Insulin glargine | Endocrine System | 34,860 |
|
Chlorphenamine 2mg/5ml oral solution sugar free
0304010G0AAAPAP
|
Chlorphenamine maleate | Chlorphenamine maleate | Respiratory System | 34,832 |
|
Humalog 100units/ml solution for injection 3ml cartridges
0601011L0BBACAC
|
Insulin Humalog | Insulin Lispro | Endocrine System | 34,810 |
|
Acidex Advance oral suspension peppermint
0101021B0BQADAL
|
Acidex (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | 34,796 |
|
Diltiazem 60mg modified-release tablets
0206020C0AAAAAA
|
Diltiazem hydrochloride | Diltiazem hydrochloride | Cardiovascular System | 34,773 |
|
Depo-Medrone with Lidocaine inj 1ml vials
1001022K0BBAGAG
|
Depo-Medrone | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 34,662 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.